Page last updated: 2024-11-05

tiopronin and Hypertrophy, Left Ventricular

tiopronin has been researched along with Hypertrophy, Left Ventricular in 1 studies

Tiopronin: Sulfhydryl acylated derivative of GLYCINE.

Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Date, MO1
Morita, T1
Yamashita, N1
Nishida, K1
Yamaguchi, O1
Higuchi, Y1
Hirotani, S1
Matsumura, Y1
Hori, M1
Tada, M1
Otsu, K1

Other Studies

1 other study available for tiopronin and Hypertrophy, Left Ventricular

ArticleYear
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model.
    Journal of the American College of Cardiology, 2002, Mar-06, Volume: 39, Issue:5

    Topics: Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Constriction, Pathologic; Disease Models, An

2002